期刊文献+

淋巴瘤样丘疹病1例 被引量:1

Lymphomatoid Papulosis: A Case Report with Literature Review on Therapy
下载PDF
导出
摘要 患者男,27岁。躯干、四肢反复发生暗红色丘疹、结节、坏死、结痂4月余,无痛,偶有瘙痒。皮肤科情况:躯干、臀部及四肢暗红色丘疹、结节,部分中央坏死、破溃,结黑褐色厚痂,留有萎缩性瘢痕或色素沉着。皮损组织病理示:真皮结节状淋巴及大组织样细胞浸润,可见多数异型细胞,约占30%,少数细胞呈双核或多核;免疫组化染色示:CD3(+),CD4(+),CD30(+),CD68(+),CD8个别(+),CD20个别(+),Ki-67约10%(+)。诊断:淋巴瘤样丘疹病。 A 27-year-old male presented with recto'rent dark red papules, nodules, mecrosis and eruss on the trunk, bultocks, arms and legs more than 4 months before. Physical examination revealed dark red papuh's, nodules on the trunk, bullocks and extremities. Some lesions were centrally necrotic, ulcerated with dark brown lhick crusts and alrophic scars or pigmentation, ttistopathologically, there were nodular lymphoid cells and large histiocytoid cells (about 30% ) infiltrale in dermis. Some were atypical with dual-core or muhicore morphnlngy. Immunohislochemically, they were diffusely positive for CD30, CD8, CD20, densely posilive for CD3, CD4, CD68. Abnut 10% cells were positive for Ki-67. A diagnosis of lymphonmtoid papulnsis was made.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第1期64-65,共2页 The Chinese Journal of Dermatovenereology
关键词 淋巴瘤样丘疹病 CD30(+) 治疗 Lymphonmloid papulosis CD30( + ) Therapy
  • 相关文献

参考文献9

  • 1Kunishige JH, McDonald H, Alvarez G, et al. Lymphomatiod papulosis and associated lymphomas:a retrospective case series of 84 patients[J]. Clin Exp Dermatol, 2009, 34(5) : 576 -581.
  • 2Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous [ J ]. Blood, 2005,105 ( 10 ) : 3768 - 3785.
  • 3LeBoit PE. Epstein-Barr virus and Lymphomatoid papulosis. Asuspect exonerated[J]. Arch Dermatol, 1996, 132(3): 335-337.
  • 4Willemze R, Dreyling M. Primary cutaneous lymphoma: FSMO clinical recommendations for diagnosis, treatment and follow-up [ J ]. Ann Oncol, 2009, 20( Suppl 4) :115 - 118.
  • 5Kempf W, Ptaltz K, Vermcer MH, et al. EORTC, ISCL and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma [ J ]. Blood, 2011, 118(15) : 4024 -4035.
  • 6Vonderheid EC, Sajjadian A, Kadin ME. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positire lymphoprolifcrative disorders[J]. J Am Acad Dermatol, 1996, 34 (3) :470 -481.
  • 7Sehmuth M, Topar G, Ulersperger B, et al. Therapeutic use of interferon-alpha for lymphomatoid papulosis [ J ]. Cancer, 2000, 89 ( 7 ) : 1603 - 1610.
  • 8Krathen RA, Ward S, Duvic M. Bexarotene is a new treatment option for lymphomatoid papulosis [ J ]. Dermatology, 2003, 206 ( 2 ) : 142 - 147.
  • 9Wu J, Wood GS. Reduction of Fas/CD95 promoter methylation,upregulation of Fas protein,and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma [ J ]. Arch Dermatol, 2011, 147 (4) : 443 - 449.

同被引文献32

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部